This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • HIV infection
  • /
  • Perspectives on the Barrier to Resistance for Dolu...
Journal

Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection

Read time: 1 mins
Published:31st Dec 2019
Author: Boffito M, Waters L, Cahn P, Paredes R, Koteff J, Van Wyk J et al.
Availability: Free full text
Ref.:AIDS Res Hum Retroviruses. 2020 Jan;36(1):13-18.
DOI:10.1089/AID.2019.0171.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest